Cerecin Inc.

New Filing
CIK: 0001293610·Biotechnology·DELAWARE·Filed: Sep 29, 2021
Total Offering

$30,000,000

Amount Sold

$10,000,001

Investors

3

First Sale

Sep 14, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Charles Stacey
Related Person
Samuel T. Henderson
Related Person
Jerris Knaisch
Related Person
Claude Nash
Related Person
Wolfgang Reichenberger
Related Person
Gurpreet Singh Vohra
Related Person
Hans-Jurgen Woerle
Related Person
Joseph S. Zakrzewski
Related Person
KiKab Kim
Related Person

Company

Accera Inc

44 COOK STREET

DENVER, CO, 80206

(303) 999-3700

SEC Filing

0001293610-21-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cerecin Inc. Form D Filing — $30,000,000 | FilingFlow